Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.553 $0.775 Thursday, 9th May 2024 BLRX stock ended at $0.685. This is 3.83% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.27% from a day low at $0.647 to a day high of $0.694.
90 days $0.553 $1.44
52 weeks $0.553 $2.53

Historical BioLineRx Ltd. prices

Date Open High Low Close Volume
Jan 24, 2023 $0.672 $0.700 $0.667 $0.675 213 990
Jan 23, 2023 $0.670 $0.690 $0.660 $0.670 278 424
Jan 20, 2023 $0.697 $0.700 $0.670 $0.678 169 712
Jan 19, 2023 $0.700 $0.700 $0.670 $0.700 179 100
Jan 18, 2023 $0.729 $0.740 $0.700 $0.705 135 616
Jan 17, 2023 $0.703 $0.740 $0.695 $0.738 446 937
Jan 13, 2023 $0.690 $0.710 $0.680 $0.690 153 500
Jan 12, 2023 $0.680 $0.680 $0.660 $0.680 182 300
Jan 11, 2023 $0.687 $0.690 $0.680 $0.689 123 022
Jan 10, 2023 $0.695 $0.700 $0.661 $0.690 200 664
Jan 09, 2023 $0.723 $0.725 $0.680 $0.698 300 728
Jan 06, 2023 $0.680 $0.720 $0.670 $0.710 263 900
Jan 05, 2023 $0.677 $0.700 $0.660 $0.686 192 373
Jan 04, 2023 $0.654 $0.700 $0.650 $0.694 381 686
Jan 03, 2023 $0.603 $0.690 $0.600 $0.650 960 733
Dec 30, 2022 $0.571 $0.600 $0.564 $0.590 317 202
Dec 29, 2022 $0.550 $0.575 $0.545 $0.573 363 877
Dec 28, 2022 $0.565 $0.594 $0.550 $0.569 185 244
Dec 27, 2022 $0.570 $0.585 $0.545 $0.566 318 910
Dec 23, 2022 $0.560 $0.600 $0.550 $0.580 234 827
Dec 22, 2022 $0.590 $0.595 $0.550 $0.572 261 907
Dec 21, 2022 $0.570 $0.602 $0.551 $0.580 162 644
Dec 20, 2022 $0.624 $0.624 $0.548 $0.590 1 188 460
Dec 19, 2022 $0.620 $0.650 $0.601 $0.615 238 205
Dec 16, 2022 $0.638 $0.660 $0.601 $0.644 233 644
Click to get the best stock tips daily for free!

About BioLineRx Ltd.

BioLineRx Ltd. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT